Chester County News and Community Website
MyChesCo is the perfect source for businesses in Philadelphia to stay informed and up-to-date with the latest business news. We provide essential information to help businesses grow, network, and hire. Our content is concise and objective, making it easy to stay informed and make well-informed decisions.
MyChesCo provides comprehensive Philadelphia business news, giving you the latest information and updates about local businesses. Our content features news about upcoming events, articles, and resources to help businesses grow and expand. We provide in-depth coverage of relevant topics and trends in the local business community, making it easy to stay informed and up-to-date.
MyChesCo also features resources to help businesses network and hire. Our content focuses on helping businesses connect with each other and build relationships. We also provide resources to help businesses find new hires and fill job openings. We make it easy for Philadelphia businesses to network and find the best talent to move their businesses forward.
Our content is comprehensive and accessible, making it easy for businesses in Philadelphia to find the information they need. Our content is updated regularly, giving you the most up-to-date news and information about local businesses. We provide concise and objective content, making it easy to stay informed and make well-informed decisions about your business.
PHILADELPHIA, PA — Five Below Inc. (Nasdaq: FIVE) is recruiting more than 50,000 seasonal employees across its stores and distribution operations as the Philadelphia-based discount retailer prepares for the 2026 …
Five Below Hires 50,000 Seasonal Workers for Holiday Sales Push Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) has regained compliance with Nasdaq’s minimum share price requirement, resolving a listing deficiency that threatened its continued eligibility to trade on the …
Medicus Pharma Regains Nasdaq Minimum Share Price Compliance Read More
PHILADELPHIA, PA — Phenom has received the highest classification in two Everest Group assessments of artificial intelligence used in recruiting and human resources, strengthening the Philadelphia-based software company’s position in …
Phenom Gains Top Rankings as AI Expands Across HR Operations Read More
PHILADELPHIA, PA — Datavault AI Inc. (Nasdaq: DVLT) is seeking a 19.9% ownership stake in DataMEDS AI Inc. (Nasdaq: MEDS) in exchange for expanded rights to its healthcare data technology, …
Datavault AI Seeks 19.9% Stake in DataMEDS Through Licensing Deal Read More
PHILADELPHIA, PA — FORT Robotics has secured approximately $20 million in additional investment commitments from existing backers, including Tiger Global and Mark Cuban Companies, as the Philadelphia-based robotics safety technology …
FORT Robotics Secures $20 Million Ahead of Nasdaq Merger Read More
PHILADELPHIA, PA — Comcast Corporation (Nasdaq: CMCSA) will pay a quarterly cash dividend of 33 cents per common share on January 27, 2027, maintaining a scheduled cash distribution to shareholders …
Comcast Sets January Dividend Payment at 33 Cents a Share Read More PHILADELPHIA, PA — Comcast Corporation (Nasdaq: CMCSA) reported a 6.1% decline in third-quarter revenue to $29.3 billion on October 22, 2026, as continued broadband customer losses and weaker residential connectivity …
Comcast Revenue Falls 6.1% as Broadband Losses Persist Read More
PHILADELPHIA, PA — Wealth management firms are increasing marketing spending and tying performance to new assets and revenue, but many still struggle to determine which investments generate business, according to …
Wealth Managers Raise Marketing Spending but Struggle to Track ROI Read More
PHILADELPHIA, PA — GSK plc (NYSE: GSK) secured U.S. Food and Drug Administration approval for Hibsago, a hepatitis B treatment that achieved functional cure in 19% of eligible clinical trial …
FDA Approves GSK’s Hibsago for Chronic Hepatitis B Read More PHILADELPHIA, PA — The U.S. Food and Drug Administration has granted accelerated approval to GSK’s Jemperli as a standalone treatment for certain patients with locally advanced rectal cancer, creating an …
FDA Approves GSK’s Jemperli for Certain Rectal Cancer Patients Read More